Atlas Trials

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Clinical trial NCT05157269 · WITHDRAWN

Trial details

NCT number
NCT05157269
Sponsor
Romark Laboratories L.C.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2024-08-01
Primary completion
2025-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.